Naturally and chemically acetylated polysaccharides: Structural characteristics, synthesis, activities, and applications in the delivery system: A review

H Li, Y Wang, P Zhao, L Guo, L Huang, X Li… - Carbohydrate Polymers, 2023 - Elsevier
Acetylated polysaccharides refer to polysaccharides containing acetyl groups on sugar
units. In the past, the acetylation modification of wall polysaccharides has been a hot …

Barriers and opportunities for gemcitabine in pancreatic cancer therapy

AK Beutel, CJ Halbrook - American Journal of Physiology …, 2023 - journals.physiology.org
Pancreatic ductal adenocarcinoma (PDA) has become one of the leading causes of cancer-
related deaths across the world. A lack of durable responses to standard-of-care …

Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation

A Queen, HN Bhutto, M Yousuf, MA Syed… - Seminars in Cancer …, 2022 - Elsevier
The primary physiological process of respiration produces carbon dioxide (CO 2) that reacts
with water molecules which subsequently liberates bicarbonate (HCO–3) and protons …

[HTML][HTML] Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance

M Capula, M Perán, G Xu, V Donati, D Yee… - Drug Resistance …, 2022 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) has one of the highest incidence/death ratios
among all neoplasms due to its late diagnosis and dominant chemoresistance. Most PDAC …

[HTML][HTML] Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance

S Jiang, T Deng, H Cheng, W Liu, D Shi, J Yuan… - Journal of Experimental …, 2023 - Springer
Background Gemcitabine resistance (GR) is a significant clinical challenge in pancreatic
adenocarcinoma (PAAD) treatment. Macrophages in the tumor immune-microenvironment …

[HTML][HTML] Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition

X Shi, M Wang, Y Zhang, X Guo, M Liu, Z Zhou… - …, 2022 - thelancet.com
Background Epidermal growth factor receptor (EGFR) is an essential target for cancer
treatment. However, EGFR inhibitor erlotinib showed limited clinical benefit in pancreatic …

Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies

J Natu, GP Nagaraju - Cancer Letters, 2023 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is considered one of the deadliest malignancies,
with dismal survival rates and extremely prevalent chemoresistance. Gemcitabine is one of …

[HTML][HTML] Current and future therapies for pancreatic ductal adenocarcinoma

Á Sally, R McGowan, K Finn, BM Moran - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic cancer is the fourth leading cause of cancer-related mortality
worldwide. The poor survival associated with this disease is due to delayed diagnosis, a …

Programmable living units for emulating pancreatic tumor‐stroma interplay

MV Monteiro, M Rocha, VM Gaspar… - Advanced Healthcare …, 2022 - Wiley Online Library
Bioengineering close‐to‐native in vitro models that emulate tumors bioarchitecture and
microenvironment is highly appreciable for improving disease modeling toolboxes. Herein …

[PDF][PDF] Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer

Y Li, S Tang, X Shi, J Lv, X Wu, Y Zhang, H Wang… - Cell Reports …, 2023 - cell.com
Metabolic reprogramming is known as an emerging mechanism of chemotherapy
resistance, but the metabolic signatures of pancreatic ductal adenocarcinomas (PDACs) …